Docetaxel in combination carboplatin as first-line treatment of patients with inoperable, locally advanced or metastatic non-small cell lung cancer

被引：0
|
作者：
Barata, F
Camacho, E
Sousa, A
Costa, MS
Resende, R
Meleiro, A
Nogueira, F
Pereira, A
Canário, D
机构：
[1] Ctr Hosp Coimbra, Coimbra, Portugal
[2] Hosp Nossa Senhora Rosario, Barreiro, Portugal
[3] Hosp Univ Coimbra, Coimbra, Portugal
[4] Hosp Distrital Santarem, Santarem, Portugal
[5] Hosp Amato Lusitano, Castelo Branco, Portugal
[6] Hosp S Bernardo, Setubal, Portugal
[7] Hosp Egas Moniz, Lisbon, Portugal
[8] Hosp Distrital Fig Foz, Figueira Foz, Portugal
[9] Hosp Garcis Orta, Almada, Portugal
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S235 / S235
页数：1
相关论文
共 50 条
  • [31] First-Line Treatment of Metastatic Non-Small Cell Lung Cancer in the Elderly
    Losanno, Tania
    Gridelli, Cesare
    CURRENT ONCOLOGY REPORTS, 2021, 23 (10)
  • [32] Gemcitabine and carboplatin combination in patients with advanced and locally advanced stage non-small cell lung cancer
    Ozturk, Nevzat
    Erbaycu, Ahmet Emin
    Gulpek, Mehmet
    Tuksavul, Fevziye
    Uslu, Ozgur
    Guclu, Salih Zeki
    TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2008, 23 (02): : 72 - 80
  • [33] First-Line Treatment of Metastatic Non-Small Cell Lung Cancer in the Elderly
    Tania Losanno
    Cesare Gridelli
    Current Oncology Reports, 2021, 23
  • [34] Docetaxel and carboplatin as first-line therapy in advanced non-small cell lung carcinoma: A phase II study
    Jahanzeb, M
    Sarna, G
    Hirsch, R
    Radice, P
    Koletsky, A
    Martinez, M
    Kruglyak, E
    Wolin, E
    Camacho, E
    Kronish, L
    Motl, S
    ANTICANCER RESEARCH, 2004, 24 (2C) : 1239 - 1242
  • [35] Bevacizumab as first-line treatment for advanced non-small cell lung cancer
    Socinski, Mark A.
    DRUGS OF TODAY, 2008, 44 (04) : 293 - 301
  • [36] Docetaxel (Taxotere®) as first-line therapy of advanced non-small cell lung cancer (NSCLC)
    Manegold, C
    ONKOLOGIE, 2003, 26 : 26 - 32
  • [37] A Randomized Phase II Study of Pemetrexed in Combination With Cisplatin or Carboplatin as First-Line Therapy for Patients With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer
    Schuette, Wolfgang H. W.
    Groeschel, Andreas
    Sebastian, Martin
    Andreas, Stefan
    Mueller, Thomas
    Schneller, Folker
    Guetz, Sylvia
    Eschbach, Corinna
    Bohnet, Sabine
    Leschinger, Monika I.
    Reck, Martin
    CLINICAL LUNG CANCER, 2013, 14 (03) : 215 - 223
  • [38] Phase II study of cetuximab in combination with carboplatin and docetaxel for patients with advanced/metastatic non-small cell lung cancer (NSCLC)
    Belani, C. P.
    Ramalingam, S.
    Schreeder, M.
    Steis, R.
    Guidice, R.
    Marshland, T.
    Butler, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [39] NAB-PACLITAXEL IN COMBINATION WITH CARBOPLATIN AS FIRST-LINE THERAPY IN DIABETIC PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Hirsh, Vera
    Owen, Scott
    Ko, Amy
    Renschler, Markus F.
    Socinski, Mark A.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S584 - S584
  • [40] A randomized phase III study of the docetaxel/carboplatin combination versus docetaxel single-agent as second line treatment for patients with advanced/metastatic Non-Small Cell Lung Cancer
    Athanasios G Pallis
    Sophia Agelaki
    Athina Agelidou
    Ioannis Varthalitis
    Kostas Syrigos
    Nikolaos Kentepozidis
    Georgia Pavlakou
    Athanasios Kotsakis
    Emmanouel Kontopodis
    Vassilis Georgoulias
    BMC Cancer, 10
12345